Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alison D. Laws, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Laws A, Kantor O, King TA. Surgical Management of the Axilla for Breast Cancer. Hematol Oncol Clin North Am. 2023 Feb; 37(1):51-77. PMID: 36435614.
    Citations:    Fields:    Translation:Humans
  2. Laws A, Katlin F, Hans M, Graichen M, Kantor O, Minami C, Bychkovsky BL, Pace LE, Scheib R, Garber JE, King TA. ASO Visual Abstract: Screening MRI Does Not Increase Cancer Detection or Result in Earlier Stage at Diagnosis in Patients with High-Risk Breast Lesions-A Propensity Score Analysis. Ann Surg Oncol. 2023 01; 30(1):78-79. PMID: 36222934.
    Citations:    Fields:    Translation:Humans
  3. Laws A, Pastorello R, Dey T, Grossmith S, King C, McGrath M, Schnitt SJ, Mittendorf EA, King T. ASO Visual Abstract: Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer. Ann Surg Oncol. 2022 11; 29(12):7737-7738. PMID: 35831521.
    Citations:    Fields:    
  4. Lyu HG, Kantor O, Laws AD, McDonald J, Pham L, Dominici LS, Vincuilla J, Raut CP, Danilchuk B, Novak L, Parker T, King TA, Mittendorf EA. Development of an Electronic Health Record Registry to Facilitate Collection of Commission on Cancer Metrics for Patients Undergoing Surgery for Breast Cancer. JCO Clin Cancer Inform. 2022 10; 6:e2200012. PMID: 36215674.
    Citations:    Fields:    Translation:Humans
  5. Laws A, Katlin F, Hans M, Graichen M, Kantor O, Minami C, Bychkovsky BL, Pace LE, Scheib R, Garber JE, King TA. Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis. Ann Surg Oncol. 2023 Jan; 30(1):68-77. PMID: 36171529.
    Citations:    Fields:    Translation:Humans
  6. Laws A, Pastorello R, Dey T, Grossmith S, King C, McGrath M, Schnitt SJ, Mittendorf EA, King T. Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer. Ann Surg Oncol. 2022 Nov; 29(12):7726-7736. PMID: 35810224.
    Citations:    Fields:    
  7. Bychkovsky B, Laws A, Katlin F, Hans M, Knust Graichen M, Pace LE, Scheib R, Garber JE, King TA. Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. Breast Cancer Res Treat. 2022 Jun; 193(2):417-427. PMID: 35378642; PMCID: PMC8978759.
    Citations:    Fields:    Translation:Humans
  8. Laws A, Katlin F, Nakhlis F, Chikarmane SA, Schnitt SJ, King TA. ASO Visual Abstract: Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision. Ann Surg Oncol. 2022 Mar; 29(3):1668-1669. PMID: 34731399.
    Citations:    Fields:    
  9. Laws A, Katlin F, Nakhlis F, Chikarmane SA, Schnitt SJ, King TA. Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision. Ann Surg Oncol. 2022 Mar; 29(3):1660-1667. PMID: 34554341.
    Citations: 2     Fields:    Translation:Humans
  10. Kantor O, Laws A, Pastorello RG, King C, Wong S, Dey T, Schnitt S, King TA, Mittendorf EA. Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2021 Nov; 28(12):7347-7355. PMID: 33956276.
    Citations: 2     Fields:    Translation:Humans
  11. Laws A, Garrido-Castro A, Poorvu P, Winer E, Mittendorf E, King T. Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer. Oncology (Williston Park). 2021 Feb 11; 35(2):77-84. PMID: 33577165.
    Citations: 3     Fields:    Translation:Humans
  12. Pastorello RG, Laws A, Grossmith S, King C, McGrath M, Mittendorf EA, King TA, Schnitt SJ. Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer. Mod Pathol. 2021 05; 34(5):875-882. PMID: 33219297.
    Citations: 2     Fields:    Translation:Humans
  13. Losk K, Freedman RA, Laws A, Kantor O, Mittendorf EA, Tan-Wasielewski Z, Trippa L, Lin NU, Winer EP, King TA. Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center. Breast Cancer Res Treat. 2021 Jan; 185(1):215-227. PMID: 32939592.
    Citations: 5     Fields:    Translation:Humans
  14. Kantor O, Wakeman M, Weiss A, Wong S, Laws A, Grossmith S, Mittendorf EA, King TA. Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer. Ann Surg Oncol. 2021 Mar; 28(3):1358-1367. PMID: 32869154.
    Citations: 6     Fields:    Translation:Humans
  15. Laws A, Mulvey TM. Implementation of a High-Risk Breast Clinic for Comprehensive Care of Women With Elevated Breast Cancer Risk Identified by Risk Assessment Models in the Community. JCO Oncol Pract. 2021 02; 17(2):e217-e225. PMID: 32822256.
    Citations: 2     Fields:    Translation:Humans
  16. Laws A, Dillon K, Kelly BN, Kantor O, Hughes KS, Gadd MA, Smith BL, Lamb LR, Specht M. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers. Ann Surg Oncol. 2020 Nov; 27(12):4819-4827. PMID: 32740737.
    Citations: 8     Fields:    Translation:Humans
  17. Laws A, Mulvey TM, Jalbert N, Dalton S, Kantor O, Harris KA, Krag KJ, Walsh EP, Coopey SB. Baseline Screening MRI Uptake and Findings in Women with =?20% Lifetime Risk of Breast Cancer. Ann Surg Oncol. 2020 Oct; 27(10):3595-3602. PMID: 32683633.
    Citations:    Fields:    Translation:Humans
  18. Laws A, Xu Y, Kong S, Brisson AM, Bouchard-Fortier A, Quan ML. Breast Biopsy During Post-treatment Surveillance of Screen-Detected Breast Cancer Patients Yields High Rates of Benign Findings. Ann Surg Oncol. 2020 Aug; 27(8):2689-2697. PMID: 32100221.
    Citations: 1     Fields:    Translation:Humans
  19. Keehn AR, Olson DW, Dort JC, Parker S, Anderes S, Headley L, Elwi A, Estey A, Crocker A, Laws A, Quan ML. Same-Day Surgery for Mastectomy Patients in Alberta: A Perioperative Care Pathway and Quality Improvement Initiative. Ann Surg Oncol. 2019 Oct; 26(10):3354-3360. PMID: 31342384.
    Citations: 11     Fields:    Translation:Humans
  20. Laws A, Crocker A, Dort J, Olson D, Elwi A, Anderes S, Parker S, Estey A, Keehn A, Quan ML. Improving Wait Times and Patient Experience Through Implementation of a Provincial Expedited Diagnostic Pathway for BI-RADS 5 Breast Lesions. Ann Surg Oncol. 2019 Oct; 26(10):3361-3367. PMID: 31342368.
    Citations: 3     Fields:    Translation:Humans
  21. Laws A, Hughes ME, Hu J, Barry WT, Dominici L, Nakhlis F, Barbie T, Duggan M, Weiss A, Rhei E, Carter K, Nimbkar S, Schnitt SJ, King TA. Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Nov; 26(12):3846-3855. PMID: 31222687.
    Citations: 3     Fields:    Translation:Humans
  22. Laws A, Brar MS, Bouchard-Fortier A, Leong B, Quan ML. Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ. J Surg Oncol. 2018 Dec; 118(7):1205-1211. PMID: 30293241.
    Citations: 3     Fields:    Translation:Humans
  23. Laws A, Anderson K, Hu J, McLean K, Novak L, Dominici LS, Nakhlis F, Carty M, Caterson S, Chun Y, Duggan M, Barry W, Connell N, Golshan M, King TA. Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy. Ann Surg Oncol. 2018 Nov; 25(12):3548-3555. PMID: 30128903.
    Citations: 5     Fields:    Translation:Humans
  24. Choi J, Laws A, Hu J, Barry W, Golshan M, King T. Margins in Breast-Conserving Surgery After Neoadjuvant Therapy. Ann Surg Oncol. 2018 Nov; 25(12):3541-3547. PMID: 30128902.
    Citations: 12     Fields:    Translation:Humans
  25. Xu Y, Bouchard-Fortier A, Olivotto IA, Cheung WY, Kong S, Kornelsen E, Laws A, Dixon E, Dort JC, Craighead PS, Quan ML. 'Driving' Rates Down: A Population-Based Study of Opening New Radiation Therapy Centers on the Use of Mastectomy for Breast Cancer. Ann Surg Oncol. 2018 Oct; 25(10):2994-3003. PMID: 29971673.
    Citations: 1     Fields:    Translation:Humans
  26. Laws A, Brar MS, Bouchard-Fortier A, Leong B, Quan ML. Intraoperative Margin Assessment in Wire-Localized Breast-Conserving Surgery for Invasive Cancer: A Population-Level Comparison of Techniques. Ann Surg Oncol. 2016 10; 23(10):3290-6. PMID: 27406094.
    Citations: 7     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Laws's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (92)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.